Literature DB >> 2893787

Autolysis-resistant peptidoglycan of anomalous composition in amino-acid-starved Escherichia coli.

E Tuomanen1, Z Markiewicz, A Tomasz.   

Abstract

Nongrowing Escherichia coli deprived of an essential amino acid continued to produce peptidoglycan at a rate approximately 30% of that of growing cells. The composition of this peptidoglycan was very different from that of growing cells and resembled that of peptidoglycan left undegraded during partial autolysis of the bacteria. Synthesis of this peptidoglycan of anomalous composition began at once upon the removal of the amino acid from the medium. Fifteen minutes of amino acid deprivation was sufficient to virtually completely prevent penicillin-induced autolytic wall degradation in vivo. During this time, although the specific activities of soluble and membrane-bound hydrolytic transglycosylases and endopeptidases remained high, the peptidoglycan produced showed decreased sensitivity to degradation in vitro. After more extensive (2-h) starvation, triggering of autolysis by chaotropic agents was also blocked. Autolysis in growing cells may be selective for peptidoglycan representing the cylindrical portion of the sacculus. It is suggested that at least part of the mechanism of the well-known lysis resistance of nongrowing E. coli is related to the deposition of structurally anomalous and relatively autolysin-resistant peptidoglycan at some strategically located sites on the bacterial surface.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2893787      PMCID: PMC210918          DOI: 10.1128/jb.170.3.1373-1376.1988

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  17 in total

1.  [ON THE MECHANISM OF ACTION OF PENICILLIN. I. ISOLATION AND CHARACTERIZATION OF PEPTIDES CONTAINING LOW MOLECULAR 2,6-DIAMINOPIMELIC ACID FROM PENICILLIN SPHEROPLASTS OF ESCHERICHIA COLI B].

Authors:  U SCHWARZ; W WEIDEL
Journal:  Z Naturforsch B       Date:  1965-02       Impact factor: 1.047

2.  Escherichia coli mutants altered in murein lipoprotein.

Authors:  H C Wu; J J Lin
Journal:  J Bacteriol       Date:  1976-04       Impact factor: 3.490

3.  Induction of autolysis in nongrowing Escherichia coli.

Authors:  E Tuomanen; A Tomasz
Journal:  J Bacteriol       Date:  1986-09       Impact factor: 3.490

4.  Changes in peptidoglycan composition and penicillin-binding proteins in slowly growing Escherichia coli.

Authors:  E Tuomanen; R Cozens
Journal:  J Bacteriol       Date:  1987-11       Impact factor: 3.490

5.  Penicillin-binding protein 7 and its relationship to lysis of nongrowing Escherichia coli.

Authors:  E Tuomanen; J Schwartz
Journal:  J Bacteriol       Date:  1987-11       Impact factor: 3.490

6.  Effect of growth rate and cell shape on the peptidoglycan composition in Escherichia coli.

Authors:  F Driehuis; J T Wouters
Journal:  J Bacteriol       Date:  1987-01       Impact factor: 3.490

7.  The rate of killing of Escherichia coli by beta-lactam antibiotics is strictly proportional to the rate of bacterial growth.

Authors:  E Tuomanen; R Cozens; W Tosch; O Zak; A Tomasz
Journal:  J Gen Microbiol       Date:  1986-05

8.  Process of cellular division in Escherichia coli growth pattern of E. coli murein.

Authors:  A Ryter; Y Hirota; U Schwarz
Journal:  J Mol Biol       Date:  1973-06-25       Impact factor: 5.469

Review 9.  Phenotypic tolerance: the search for beta-lactam antibiotics that kill nongrowing bacteria.

Authors:  E Tuomanen
Journal:  Rev Infect Dis       Date:  1986 Jul-Aug

10.  Newly made enzymes determine ongoing cell wall synthesis and the antibacterial effects of cell wall synthesis inhibitors.

Authors:  E Tuomanen
Journal:  J Bacteriol       Date:  1986-08       Impact factor: 3.490

View more
  21 in total

Review 1.  Life after log.

Authors:  D A Siegele; R Kolter
Journal:  J Bacteriol       Date:  1992-01       Impact factor: 3.490

2.  Membrane intermediates in the peptidoglycan metabolism of Escherichia coli: possible roles of PBP 1b and PBP 3.

Authors:  Y van Heijenoort; M Gómez; M Derrien; J Ayala; J van Heijenoort
Journal:  J Bacteriol       Date:  1992-06       Impact factor: 3.490

Review 3.  VanX, a bacterial D-alanyl-D-alanine dipeptidase: resistance, immunity, or survival function?

Authors:  I A Lessard; C T Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

4.  Sulfur and nitrogen limitation in Escherichia coli K-12: specific homeostatic responses.

Authors:  Prasad Gyaneshwar; Oleg Paliy; Jon McAuliffe; David L Popham; Michael I Jordan; Sydney Kustu
Journal:  J Bacteriol       Date:  2005-02       Impact factor: 3.490

5.  Influence of growth media on Escherichia coli cell composition and ceftazidime susceptibility.

Authors:  F Malouin; S Chamberland; N Brochu; T R Parr
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

6.  Lysis of Escherichia coli by beta-lactams which bind penicillin-binding proteins 1a and 1b: inhibition by heat shock proteins.

Authors:  J K Powell; K D Young
Journal:  J Bacteriol       Date:  1991-07       Impact factor: 3.490

Review 7.  Peptidoglycan hydrolases of Escherichia coli.

Authors:  Jean van Heijenoort
Journal:  Microbiol Mol Biol Rev       Date:  2011-12       Impact factor: 11.056

8.  Chemically Induced Cell Wall Stapling in Bacteria.

Authors:  Sylvia L Rivera; Akbar Espaillat; Arjun K Aditham; Peyton Shieh; Chris Muriel-Mundo; Justin Kim; Felipe Cava; M Sloan Siegrist
Journal:  Cell Chem Biol       Date:  2020-11-24       Impact factor: 8.116

9.  Plasmid regulation and temperature-sensitive behavior of the Yersinia pestis penicillin-binding proteins.

Authors:  R C Ferreira; J T Park; L C Ferreira
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

10.  Modification in penicillin-binding proteins during in vivo development of genetic competence of Haemophilus influenzae is associated with a rapid change in the physiological state of cells.

Authors:  M Dargis; P Gourde; D Beauchamp; B Foiry; M Jacques; F Malouin
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.